Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Clinical trial NCT00286429 · COMPLETED

Trial details

NCT number: NCT00286429
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2006-02-01
Primary completion: 2007-05-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.